COGT - CIK 0001622229
Cogent Biosciences, Inc. has filed 595 documents with the SEC between 2014 and 2026. The most frequent type is insider trade (207 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2026-05-21 | 2026-05-19 |
| SCHEDULE 13G/A | - | 2026-05-14 | - |
| Quarterly report | 10-Q | 2026-05-05 | 2026-03-31 |
| Major company event | 8-K | 2026-05-05 | 2026-05-05 |
| Annual report to shareholders | ARS | 2026-04-23 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-23 | - |
| Proxy statement | DEF 14A | 2026-04-23 | 2026-06-09 |
| Insider trade | 4 | 2026-04-03 | 2026-04-01 |
| Insider sale notice | 144 | 2026-03-31 | - |
| Insider trade | 4 | 2026-03-31 | 2026-03-31 |
| SCHEDULE 13D/A | - | 2026-03-31 | - |
| SCHEDULE 13G/A | - | 2026-03-26 | - |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| Employee stock plan | S-8 | 2026-02-17 | - |
| Annual report | 10-K | 2026-02-17 | 2025-12-31 |
| Major company event | 8-K | 2026-02-17 | 2026-02-17 |
| SCHEDULE 13G/A | - | 2026-01-30 | - |
| Insider trade | 4 | 2026-01-22 | 2026-01-22 |
| Insider sale notice | 144 | 2026-01-22 | - |
| SCHEDULE 13D/A | - | 2026-01-22 | - |
| SCHEDULE 13G/A | - | 2026-01-21 | - |
| SCHEDULE 13G/A | - | 2026-01-21 | - |
| Insider trade | 4 | 2026-01-05 | 2026-01-01 |
| Insider trade | 4 | 2025-12-30 | 2025-12-26 |
| Insider trade | 4 | 2025-12-30 | 2025-12-26 |
| Insider trade | 4 | 2025-12-30 | 2025-12-26 |
| Insider trade | 4 | 2025-12-30 | 2025-12-26 |
| Insider sale notice | 144 | 2025-12-29 | - |
| Insider sale notice | 144 | 2025-12-29 | - |
| Insider sale notice | 144 | 2025-12-29 | - |
| Insider sale notice | 144 | 2025-12-29 | - |
| Insider trade | 4 | 2025-12-19 | 2025-12-17 |
| Insider trade | 4 | 2025-12-19 | 2025-12-17 |
| Insider trade | 4 | 2025-12-19 | 2025-12-17 |
| Insider trade | 4 | 2025-12-19 | 2025-12-17 |
| Insider trade | 4 | 2025-12-19 | 2025-12-17 |
| Insider trade | 4 | 2025-12-19 | 2025-12-17 |
| Major company event | 8-K | 2025-12-08 | 2025-12-06 |
| Major company event | 8-K | 2025-11-18 | 2025-11-18 |
| SCHEDULE 13D/A | - | 2025-11-17 | - |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| Major company event | 8-K | 2025-11-13 | 2025-11-11 |
| Prospectus supplement | 424B5 | 2025-11-12 | - |
| Prospectus supplement | 424B5 | 2025-11-12 | - |
| Free writing prospectus | FWP | 2025-11-12 | - |